A detailed history of Aspire Growth Partners LLC transactions in Dexcom Inc stock. As of the latest transaction made, Aspire Growth Partners LLC holds 4,834 shares of DXCM stock, worth $433,513. This represents 0.37% of its overall portfolio holdings.

Number of Shares
4,834
Holding current value
$433,513
% of portfolio
0.37%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$65.68 - $81.01 $317,497 - $391,602
4,834 New
4,834 $376 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $34.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Aspire Growth Partners LLC Portfolio

Follow Aspire Growth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Growth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Growth Partners LLC with notifications on news.